The Effect of MediYoga on Quality of Sleep, Blood Pressure and Quality of Life Among Older People: a Randomized Controlled Study

Status: Recruiting
Location: See location...
Intervention Type: Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this Randomized Controlled Trial is to test if an intervention consisting of Yoga can increase quality of sleep and health related quality of life and decrease BP. Secondary to explore and describe the implementation of a yoga intervention and the participants' experiences and perspectives on the intervention in a process evaluation. The main question it aims to contribute knowledge about intervention of Yoga in a home environment for individuals with hypertension aged 65 years or older. Participants will (if they got selected into one of the two interventions groups), participate in Yoga exercises delivered by an app for 2 times a week for 10 weeks. Researchers will compare the intervention groups with the control group to see if Medi yoga has an effect in older people with hypertension.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:

• Older people ≥65 years

• Diagnosed with hypertension.

• Speaking and reading Danish.

• Being able to consent.

• No comorbidity that restricts them from participating in the intervention.

• Being the owner or user of a smartphone or tablet.

Locations
Other Locations
Denmark
Herlev and Gentofte Hospital
RECRUITING
Herlev
Contact Information
Primary
Katrine Amdi, MSc
katrine.vollbrecht.amdi@regionh.dk
+4538673867
Backup
Signe Risom, associated Prof.
signe.stelling.risom@regionh.dk
Time Frame
Start Date: 2024-11-04
Estimated Completion Date: 2026-07
Participants
Target number of participants: 180
Treatments
Experimental: Intervention group I, yoga 20 minutes x2 pr week
Experimental: Intervention Group II, yoga 40 minutes pr week
Other: Control group, no intervention
standard of care
Related Therapeutic Areas
Sponsors
Leads: Herlev and Gentofte Hospital

This content was sourced from clinicaltrials.gov